Top compounds associated with response to EDDM3A


Feature Type Standardized
Nominal ANOVA
mRNA PD318088 CTRPv2 pan-cancer AAC -0.08 0.02
mRNA XMD14-99 GDSC1000 pan-cancer AAC -0.076 0.02
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.02
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.02
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.067 0.02
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.074 0.02
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.068 0.02
mRNA Rapamycin gCSI pan-cancer AAC -0.12 0.02
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.1 0.03
mRNA PF-3758309 CTRPv2 pan-cancer AAC -0.094 0.03
Download CSV